Chemoinformaics analysis of TANAPARTHIN-BETA-PEROXIDE
Molecular Weight | 278.304 | nRot | 0 |
Heavy Atom Molecular Weight | 260.16 | nRig | 20 |
Exact Molecular Weight | 278.115 | nRing | 4 |
Solubility: LogS | -2.937 | nHRing | 2 |
Solubility: LogP | 1.435 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 41.0623 |
nHD | 1 | BPOL | 22.3977 |
QED | 0.313 |
Synth | 5.854 |
Natural Product Likeliness | 3.539 |
NR-PPAR-gamma | 0.929 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.083 |
Pgp-sub | 0 |
HIA | 0.071 |
CACO-2 | -4.823 |
MDCK | 0.000026 |
BBB | 0.847 |
PPB | 0.577991 |
VDSS | 1.05 |
FU | 0.457282 |
CYP1A2-inh | 0.057 |
CYP1A2-sub | 0.888 |
CYP2c19-inh | 0.117 |
CYP2c19-sub | 0.84 |
CYP2c9-inh | 0.105 |
CYP2c9-sub | 0.088 |
CYP2d6-inh | 0.125 |
CYP2d6-sub | 0.376 |
CYP3a4-inh | 0.565 |
CYP3a4-sub | 0.642 |
CL | 6.1 |
T12 | 0.244 |
hERG | 0.034 |
Ames | 0.077 |
ROA | 0.987 |
SkinSen | 0.088 |
Carcinogencity | 0.948 |
EI | 0.017 |
Respiratory | 0.983 |
NR-Aromatase | 0.914 |
Antiviral | Yes |
Prediction | 0.795308 |